SELECT: Cardiovascular Protection Independent of Diabetes Status The SELECT trial (N=17,604) tested semaglutide 2.4 mg against placebo in adults with established cardiovascular disease, a BMI of 27 or greater, and no diabetes [11]
Pteroic acid is then converted to folic acid through the N -esterification of glutamic acid to the carboxylic acid of the PABA portion of pteroic acid
Given the limited capacity of the brain to synthesize lipids, it must rely on the supply of lipids from the peripheral circulation
The drug was first approved to treat type 2 diabetes, but since the discovery of its weight loss benefits, it has been FDA-approved for helping people lose weight
Certain medical conditions may restrict tirzepatide usage, such as a history of pancreatitis, medullary thyroid cancer, or severe gastrointestinal disorders
This includes following a healthy diet, increasing physical activity, and developing habits that promote overall wellness
